Addus HomeCare Corp. (NASDAQ: ADUS) has a number of deals in its mergers and acquisition pipeline, some expected to occur in the fourth quarter. The company is leaning its M&A activity towards personal care and home health, but hospice transactions may be in the cards as they work to build density in markets where they […]
Addus HomeCare Corp. (NASDAQ: ADUS) is on the hunt for acquisitions. While its 2021 acquisition strategy is heavily weighted toward home health and personal care, the company still has its eyes out for hospice assets. Addus provides hospice, home health and personal care services to nearly 44,000 patients through 215 locations in 25 states. The […]
Addus HomeCare (NASDAQ: ADUS) has secured a $600 million revolving line of credit, with Capital One Financial Corp. (NYSE: COF) as the lead arranger and administrative agent. The company intends to apply the credit to pursue further acquisitions. Addus is on the hunt for acquisitions. While its 2021 acquisition strategy is heavily weighted toward home […]
Addus HomeCare Corporation (NASDAQ: ADUS) is on the hunt for acquisitions. While its 2021 acquisition strategy is heavily weighted toward home health and personal care, the company has its eyes out for hospice assets. This is evidenced by the recent acquisition of Armada Hospice of New Mexico and Armada Hospice of Santa Fe for $29 […]
In a $29 million deal, Addus HomeCare Corporation (NASDAQ: ADUS), has signed a definitive agreement to purchase three affiliated entities: Armada Skilled Home Health of New Mexico, LLC, Armada Hospice of New Mexico, LLC and Armada Hospice of Santa Fe, LLC. The Addus acquisition strategy is focused on co-locating its clinical hospice and home health […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
